Regeneron Pharmaceuticals will share in development of Tessera Therapeutics’ TSRA-196, a Phase 1-ready gene-editing therapy for alpha-1 antitrypsin deficiency (AATD). Other companies developing genetic medicines for this rare disease include Beam Therapeutics, Wave Life Sciences, Korro Bio, and AIRNA. The post Regeneron Puts Up $150M to Partner on Tessera Gene-Editing Med for Rare Liver &…
Americans largely trust their doctors but are skeptical of payers, drugmakers and hospital leadership — a divide fueled by rising costs and a complex, opaque healthcare system. Kristin Wikelius of United States of Care said restoring confidence will require more transparency, simpler navigation and policies that prioritize preventive care. The post What Is Needed to…
The healthcare industry is contending with a difficult question: how to properly wield AI without taking on too much risk? Inherent in this battle is the role of humans. Here’s how Merck’s chief data officer is viewing AI. The post For Merck, AI Puts Humans In the “Right Room” appeared first on MedCity News.
Strategic planning for the upcoming measurement year should incorporate thorough communication between the health plan, its HEDIS vendor, and auditor. The post Building a Foundation for HEDIS Success Amid Change appeared first on MedCity News.
The challenge is not just to minimize harm, but to make choices that expand human flourishing rather than reduce us to more efficient workers or more predictable consumers. The post The Ethical Frontiers of Brain-Computer Interfaces appeared first on MedCity News.
Protego Biopharma’s lead program is a potential treatment for the rare disease light chain amyloidosis. The startup says the novel mechanism of its oral small molecule should have better outcomes than antibodies from AstraZeneca and Prothena that failed their respective pivotal studies in the disorder earlier this year. The post Startup Protego Bio Lands $130M…
In this episode, we’re joined by Liz Powell, founder of Women’s Health Advocates. We discussed the organization’s policy priorities in the women’s health space. The post MedCity FemFwd: How Women’s Health Advocates Is Pushing for Change appeared first on MedCity News.
If HSAs and FSAs were functioning as originally intended, the rising out-of-pocket costs faced by most Americans would be met with increased financial fluency and agency. The post HSAs And FSAs Were Designed to Give Consumers Control and Clarity of Their Healthcare Spending — Why Isn’t This Happening? appeared first on MedCity News.
It’s a truth that many healthcare communicators overlook: the mental health crisis spans generations, yet the way people engage with mental health content is deeply shaped by age, experience and culture. The post Four Generations, One Conversation: Bridging the Mental Health Messaging Gap appeared first on MedCity News.
All of us can see glaring issues with the healthcare system that need to be addressed — but system-level change is hard. The leap to VBC isn’t easy, but the results are undeniable. The post Reclaiming the Joy of Medicine: How Value-Based Care Can Restore Physician Purpose appeared first on MedCity News.